# The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study

> **NCT06830512** · NA · RECRUITING · sponsor: **Xijing Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Heart Neoplasms

## Interventions

- **PROCEDURE:** Echocardiography-guided percutaneous radiofrequency ablation for cardiac tumors

## Key facts

- **NCT ID:** NCT06830512
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-24
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06830512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06830512, "The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06830512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*